- Home
- / Alpine Immune Sciences
Alpine Immune Sciences
Revenue
$58.9 M
FY, 2023
Alpine Immune Sciences Summary
Company Summary
- Overview
- Alpine Immune Sciences is a biotechnology company that develops protein-based immunotherapies. It offers product candidates for inflammatory and autoimmune diseases and cancer.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2015
- HQ
- Seattle, WA, US | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Robert Conway, Director
Min Cui, Director
Jan Hillson, Senior VP of Clinical Development
LocationsView all
1 location detected
Seattle, WA HQ
United States
188 E Blaine St #200
Alpine Immune Sciences Financials
Summary Financials
- Revenue (Q1, 2024)
- $7.0M
- Net income (Q1, 2024)
- ($17.9M)
- Cash (Q1, 2024)
- $33.0M
- EBIT (Q1, 2024)
- ($22.7M)